Pablo de Renteria
Stock Analyst at Kepler Capital
(0.46)
# 4,365
Out of 5,005 analysts
346
Total ratings
42.9%
Success rate
-3.3%
Average return
Main Sectors:
Stocks Rated by Pablo de Renteria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIT: DIA DiaSorin S.p.A. | Downgraded: Hold | €76.00 | €79.28 | -4.14% | 2 | Sep 2, 2026 | |
| EPA: BIM bioMérieux S.A. | Reiterated: Buy | €85.00 | €79.70 | +6.65% | 1 | Jun 25, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 670.00 | CHF 584.20 | +14.69% | 15 | May 8, 2026 | |
| BME: IDR Indra Sistemas, S.A. | Reiterated: Buy | €76.00 | €60.08 | +26.50% | 27 | May 6, 2026 | |
| BME: ROVI Laboratorios Farmaceuticos Rovi, S.A. | Reiterated: Buy | €90.00 → €83.00 | €59.95 | +38.45% | 36 | May 6, 2026 | |
| SWX: SFZN Siegfried Holding AG | Reiterated: Hold | CHF 85.00 | CHF 73.45 | +15.72% | 5 | Apr 24, 2026 | |
| BME: VIS Viscofan, S.A. | Reiterated: Buy | €74.00 | €53.70 | +37.80% | 56 | Apr 24, 2026 | |
| BME: EBRO Ebro Foods, S.A. | Reiterated: Hold | €18.10 | €18.32 | -1.20% | 40 | Feb 24, 2026 | |
| BME: ALM Almirall, S.A. | Reiterated: Buy | €13.30 → €14.20 | €10.56 | +34.47% | 49 | Feb 23, 2026 | |
| BME: FDR Fluidra, S.A. | Reiterated: Sell | €19.20 | €18.12 | n/a | 66 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €4.20 | €2.37 | n/a | 13 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €5.00 | €2.73 | n/a | 11 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $7.41 | n/a | 17 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €17.50 | €9.77 | n/a | 1 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €99.00 → €105.00 | €72.00 | n/a | 3 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 9,500p | 12,492p | n/a | 1 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €28.70 → €32.00 | €53.34 | n/a | 2 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €2.35 | €0.66 | n/a | 1 | Jul 29, 2019 |
DiaSorin S.p.A.
Sep 2, 2026
Downgraded: Hold
Price Target: €76.00
Current: €79.28
Upside: -4.14%
bioMérieux S.A.
Jun 25, 2026
Reiterated: Buy
Price Target: €85.00
Current: €79.70
Upside: +6.65%
Lonza Group AG
May 8, 2026
Reiterated: Buy
Price Target: CHF 670.00
Current: CHF 584.20
Upside: +14.69%
Indra Sistemas, S.A.
May 6, 2026
Reiterated: Buy
Price Target: €76.00
Current: €60.08
Upside: +26.50%
Laboratorios Farmaceuticos Rovi, S.A.
May 6, 2026
Reiterated: Buy
Price Target: €90.00 → €83.00
Current: €59.95
Upside: +38.45%
Siegfried Holding AG
Apr 24, 2026
Reiterated: Hold
Price Target: CHF 85.00
Current: CHF 73.45
Upside: +15.72%
Viscofan, S.A.
Apr 24, 2026
Reiterated: Buy
Price Target: €74.00
Current: €53.70
Upside: +37.80%
Ebro Foods, S.A.
Feb 24, 2026
Reiterated: Hold
Price Target: €18.10
Current: €18.32
Upside: -1.20%
Almirall, S.A.
Feb 23, 2026
Reiterated: Buy
Price Target: €13.30 → €14.20
Current: €10.56
Upside: +34.47%
Fluidra, S.A.
Jul 31, 2025
Reiterated: Sell
Price Target: €19.20
Current: €18.12
Upside: n/a
Jul 23, 2025
Reiterated: Buy
Price Target: €4.20
Current: €2.37
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: €5.00
Current: €2.73
Upside: n/a
Feb 29, 2024
Reiterated: Buy
Price Target: $19
Current: $7.41
Upside: n/a
Apr 21, 2023
Initiated Coverage: Buy
Price Target: €17.50
Current: €9.77
Upside: n/a
Dec 10, 2021
Reiterated: Buy
Price Target: €99.00 → €105.00
Current: €72.00
Upside: n/a
Dec 10, 2021
Reiterated: Buy
Price Target: 9,500p
Current: 12,492p
Upside: n/a
Mar 18, 2020
Downgraded: Hold
Price Target: €28.70 → €32.00
Current: €53.34
Upside: n/a
Jul 29, 2019
Reiterated: Buy
Price Target: €2.35
Current: €0.66
Upside: n/a